Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/23964
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Akhtardanesh, Baharak | - |
dc.date.accessioned | 2022-01-10T08:59:47Z | - |
dc.date.available | 2022-01-10T08:59:47Z | - |
dc.date.issued | 2011 | - |
dc.identifier.citation | Temizel, E. M. vd. (2011). "Effect of prednisolone and cetirizine on D. farinae and histamine-induced wheal and flare response in healthy dogs". Tierarztliche Praxis Ausgabe Kleintiere Heimtiere, 39(1), 25-30. | en_US |
dc.identifier.issn | 1434-1239 | - |
dc.identifier.issn | 2567-5842 | - |
dc.identifier.uri | https://pubmed.ncbi.nlm.nih.gov/22143560/ | - |
dc.identifier.uri | http://hdl.handle.net/11452/23964 | - |
dc.description.abstract | Objective: Prednisolone and antihistamines are highly potent drugs in the treatment of atopic dermatitis and widely used in humans and dogs. In some atopic patients in which antihistamines, corticosteroids or other drugs have already been administered intradermal testing (IDT) may be necessary. The aim of the present study was to compare the effects of cetirizine and prednisolone on IDT results. Material and methods: Thirty healthy dogs (average age 5.9 +/- 0.6 years) were randomly assigned to three groups. Treatment groups were administered prednisolone (1 mg/kg BW daily, tapering dosage; group I), cetirizine (1 mg/kg BW daily; group II) and placebo (group III) respectively for one week. In the second week, none of the dogs received any medications. IDT was performed prior to drug administration and results obtained were considered as the baseline response. Second and third IDTs were performed at the end of the first and second week, respectively. Results: In groups I and II IDT reactivity was reduced at the end of first week (p < 0.05). After drug discontinuation the reactivity almost returned to baseline at the end of the 2-week period, with the exception of the prednisolone group for D. farinae. Conclusion: Prednisolone and cetirizine have significant effects on IDI reactions and must be withdrawn by veterinary practitioners up to 2 weeks prior to IDT. | en_US |
dc.language.iso | en | en_US |
dc.publisher | George Thieme Verlag | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Veterinary sciences | en_US |
dc.subject | Intradermal testing | en_US |
dc.subject | Atopia | en_US |
dc.subject | Antihistamines | en_US |
dc.subject | Canine | en_US |
dc.subject | Canine atopic-dermatitis | en_US |
dc.subject | Late-phase reactions | en_US |
dc.subject | Acvd task-force | en_US |
dc.subject | Hydrocortisone conditioner | en_US |
dc.subject | Cutaneous reactivity | en_US |
dc.subject | Paf-acether | en_US |
dc.subject | Skin | en_US |
dc.subject | Inhibition | en_US |
dc.subject | Pharmacodynamics | en_US |
dc.subject | Antihistamine | en_US |
dc.subject | Canis familiaris | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Anti-allergic agents | en_US |
dc.subject.mesh | Anti-inflammatory agents | en_US |
dc.subject.mesh | Cetirizine | en_US |
dc.subject.mesh | Dermatitis, atopic | en_US |
dc.subject.mesh | Dermatophagoides farinae | en_US |
dc.subject.mesh | Dog diseases | en_US |
dc.subject.mesh | Dogs | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Histamine | en_US |
dc.subject.mesh | Injections, intradermal | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Prednisolone | en_US |
dc.title | Effect of prednisolone and cetirizine on D. farinae and histamine-induced wheal and flare response in healthy dogs | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000288827700005 | tr_TR |
dc.identifier.scopus | 2-s2.0-84866603611 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Veterinerlik Fakültesi/İç Hastalıkları Anabilim Dalı. | tr_TR |
dc.identifier.startpage | 25 | tr_TR |
dc.identifier.endpage | 30 | tr_TR |
dc.identifier.volume | 39 | tr_TR |
dc.identifier.issue | 1 | tr_TR |
dc.relation.journal | Tierarztliche Praxis Ausgabe Kleintiere Heimtiere | de |
dc.contributor.buuauthor | Temizel, Ethem Mutlu | - |
dc.contributor.buuauthor | Ci̇han, Hüseyin | - |
dc.contributor.buuauthor | Aytuǧ, Nilüfer | - |
dc.contributor.researcherid | ABH-3742-2020 | tr_TR |
dc.relation.collaboration | Yurt dışı | tr_TR |
dc.identifier.pubmed | 22143560 | tr_TR |
dc.subject.wos | Veterinary sciences | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | Pubmed | en_US |
dc.contributor.scopusid | 26430270100 | tr_TR |
dc.contributor.scopusid | 6602381681 | tr_TR |
dc.contributor.scopusid | 6505835923 | tr_TR |
dc.subject.scopus | Atopic Dermatitis; Oclacitinib; Allergens | en_US |
dc.subject.emtree | Antiallergic agent | en_US |
dc.subject.emtree | Antiinflammatory agent | en_US |
dc.subject.emtree | Cetirizine | en_US |
dc.subject.emtree | Histamine | en_US |
dc.subject.emtree | Prednisolone | en_US |
dc.subject.emtree | Animal | en_US |
dc.subject.emtree | Animal disease | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Atopic dermatitis | en_US |
dc.subject.emtree | Clinical trial | en_US |
dc.subject.emtree | Controlled clinical trial | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Dermatophagoides farinae | en_US |
dc.subject.emtree | Dog | en_US |
dc.subject.emtree | Dog disease | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Immunology | en_US |
dc.subject.emtree | Intradermal drug administration | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Randomized controlled trial | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.